Discussion on gemcitabine combined with targeted drugs in the treatment of pancreatic cancer

被引:3
作者
Huang, Jun-Hao [1 ]
Guo, Wei [1 ]
Liu, Zhe [1 ,2 ]
机构
[1] China Med Univ, Hosp 1, Dept Pancreat Biliary Surg, Shenyang 110001, Liaoning, Peoples R China
[2] China Med Univ, Hosp 1, Dept Pancreat Biliary Surg, 155 Nanjing North St, Shenyang 110001, Liaoning, Peoples R China
关键词
Pancreatic cancer; Chemotherapy; Targeted therapy; Gemcitabine; Drug; Combination; SURVIVAL; THERAPY;
D O I
10.3748/wjg.v29.i3.579
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Pancreatic cancer is a malignant tumor with poor prognosis. The treatment of pancreatic cancer depends on the tumor stage and type, and includes local treatment (surgery, radiotherapy and ablation intervention) and systemic therapy (chemotherapy, targeted therapy and immunotherapy). We read with great interest the review "Effective combinations of anti-cancer and targeted drugs for pancreatic cancer treatment" published on World J Gastroenterol and intended to share some of our perspectives in pancreatic cancer treatment. This review presents the therapeutic effects of the combination of gemcitabine and targeted drugs, which gives us a deeper insight into the combination treatments for pancreatic cancer.
引用
收藏
页码:579 / 581
页数:3
相关论文
共 50 条
[31]   EGFR Targeted PLGA Nanoparticles Using Gemcitabine for Treatment of Pancreatic Cancer [J].
Aggarwal, Sahil ;
Yadav, Sachin ;
Gupta, Swati .
JOURNAL OF BIOMEDICAL NANOTECHNOLOGY, 2011, 7 (01) :137-138
[32]   Synergistic antitumor activity of gemcitabine combined with triptolide in pancreatic cancer cells [J].
Qiao, Zhixin ;
He, Min ;
He, Mu ;
Li, Weijing ;
Wang, Xuanlin ;
Wang, Yanbing ;
Kuai, Qiyuan ;
Li, Changlan ;
Ren, Suping ;
Yu, Qun .
ONCOLOGY LETTERS, 2016, 11 (05) :3527-3533
[33]   Prolonged complete response following gemcitabine-erlotinib combined therapy in advanced pancreatic cancer [J].
Czarnecka, Anna M. ;
Korzen, Piotr ;
Nowak-Dement, Anna ;
Kukwa, Wojciech ;
Korniluk, Jan ;
Szczylik, Cezary .
ONCOLOGY LETTERS, 2016, 11 (02) :1101-1104
[34]   Comparison of the efficacy and the toxicity between gemcitabine with capecitabine (GC) and gemcitabine with erlotinib (GE) in unresectable pancreatic cancer [J].
Jeon, Eun Kyoung ;
Won, Hye-Sung ;
Ko, Yoon-Ho ;
Lee, In Seok ;
Hong, Tae Ho ;
You, Young Kyoung ;
Lee, Myung Ah .
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2012, 138 (10) :1625-1630
[35]   The role of autophagy in the treatment of pancreatic cancer with gemcitabine and ionizing radiation [J].
Mukubou, Hideyo ;
Tsujimura, Toshiaki ;
Sasaki, Ryohei ;
Ku, Yonson .
INTERNATIONAL JOURNAL OF ONCOLOGY, 2010, 37 (04) :821-828
[36]   The clinical efficacy of S-1 combined with gemcitabine in senile patients with advanced pancreatic cancer and the drugs' effects on quality of life [J].
Liu, Yuqiang ;
Wang, Yu ;
Hou, Chunxia .
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2020, 13 (03) :1744-1750
[37]   Gemcitabine-induced radiation recall in the treatment of pancreatic cancer [J].
Zainon, Wan Mohd Nazri Wan ;
Borg, M. ;
Higgs, B. ;
Yeoh, E. ;
Kotasek, D. ;
Parnis, F. ;
Hillenband, E. ;
Hamzah, S. .
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2009, 5 (01) :17-23
[38]   Gemcitabine Adjuvant Therapy for Resected Pancreatic Cancer A Meta-analysis [J].
Yu, Zhong ;
Zhong, Wa ;
Tan, Zhi-Ming ;
Wang, Ling-Yun ;
Yuan, Yu-Hong .
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2015, 38 (03) :322-325
[39]   A prospective randomised phase-II trial with gemcitabine versus gemcitabine plus sunitinib in advanced pancreatic cancer [J].
Bergmann, L. ;
Maute, L. ;
Heil, G. ;
Ruessel, J. ;
Weidmann, E. ;
Koeberle, D. ;
Fuxius, S. ;
Weigang-Koehler, K. ;
Aulitzky, W. E. ;
Woermann, B. ;
Hartung, G. ;
Moritz, B. ;
Edler, L. ;
Burkholder, I. ;
Scheulen, M. E. ;
Richly, H. .
EUROPEAN JOURNAL OF CANCER, 2015, 51 (01) :27-36
[40]   Erlotinib plus gemcitabine versus gemcitabine for pancreatic cancer: real-world analysis of Korean national database [J].
Shin, Sangjin ;
Park, Chan Mi ;
Kwon, Hanbyeol ;
Lee, Kyung-Hun .
BMC CANCER, 2016, 16